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Effect of Dam Parity on Growth Performance 
and Immunity of Weaned Pigs
Growth performance in the nursery may be affected by dam parity.
Erin E. Carney
Huyen Tran
Justin W. Bundy
Roman Moreno
Phillip S. Miller
Thomas E. Burkey1
Summary 
The growth performance of weaned 
pigs derived from different parities has 
not been previously evaluated; however, 
unpublished and anecdotal observations 
suggest that progeny derived from fi rst 
parity (P1) dams have reduced health 
status and growth performance com-
pared to progeny derived from mature 
sows (≥ P2). The objective of the cur-
rent study was to evaluate the effect of 
dam parity on growth performance and 
immune response of P1 and P4 progeny 
during the nursery phase of production. 
Results from this experiment suggest 
that P4 progeny have increased body 
weight and growth performance during 
the nursery phase of production com-
pared to P1 progeny. There were no ef-
fects of dam parity on immune response 
in this experiment. 
Introduction
Parity segregation is used on some 
commercial swine farms. Parity 1 
progeny are often segregated from the 
progeny of more mature dams 
(≥ P2) because of decreased growth 
performance and higher mortality 
rates. The effect of dam parity on 
progeny growth performance is not 
fully understood . However, it has been 
generally accepted that P1 progeny 
have reduced growth performance 
when compared to progeny of mature 
dams. This could be due to a lower 
health status in P1 progeny, causing 
decreased average daily gain (ADG) 
and increased mortality. Unpublished 
data suggest that P1 progeny have 
reduced weaning weight, decreased 
nursery and fi nishing ADG, and 
greater mortality than P2 progeny. 
The objective of the current study was 
to evaluate the effect of dam parity 
on growth performance and immune 
response of P1 and P4 progeny during 
the nursery phase of production.
Materials and Methods
Experimental Design
The experimental protocol was 
reviewed and approved by the Institu-
tional Animal Care and Use committee 
of the University of Nebraska–Lincoln. 
A total of 96 weaned pigs were used in 
a 42-day study that is a continuation 
of the experiment described in a previ-
ous report (see previous article: “Effect 
of Dam Parity on Litter Performance 
and Passive Immunity”). To obtain an 
accurate representation of body weight 
(BW) as the pigs were removed from 
the farrowing house, BW was averaged 
within parity (P1 or P4), and pigs were 
selected based on the average BW of 
each parity. Initial BW of P1 and P4 
pigs averaged 12.56 and 13.98 + 0.1 lb, 
respectively. 
Six pigs were housed in each pen 
with four replications per treatment. 
Pigs within each parity were allotted 
to one of two dietary treatments, a 
control diet (CTL) or the CTL diet 
with the antibiotic Mecadox (50 lb/
ton; AB). This created four treatments 
for the nursery study, consisting of: 1) 
P1, CTL; 2) P1, AB; 3) P4, CTL; and 4) 
P4, AB (Table 1). All diets were fed in 
meal form and formulated to meet or 
exceed NRC requirements for growth. 
Pigs were fed in three phases: Phase 
I (day 0 to 7); Phase II (day 8 to 21); 
and Phase III (day 22 to 42). Pigs were 
housed in a temperature-controlled 
room and each pen contained a single 
nipple waterer and a single self-feeder 
to facilitate ad-libi tum access to water 
and feed. Weight and feed disappear-
ance were recorded on day 7, 21, and 
42. Average daily gain, average daily 
feed intake (ADFI), and ADG:ADFI 
(G:F) were estimated based on the 
weekly pen BW and feed disappear-
ance.
Table 1. Composition of phase 1, 2, and 3 diets (as-fed basis) %. 
  Control   Antibiotics
Ingredients (%) Phase 1  Phase 2 Phase 3 Phase 1 Phase 2 Phase 3
Corn 44.4 43.9 60.2 43.4 42.9 59.2
Soybean meal, 47.5% CP 14.8 32.0 33.8 14.8 32.0 33.8
Whey, dried 22.5 15.0 0.0 22.5 15.0 0.0
Fish meal 8.0 4.0 0.0 8.0 4.0 0.0
Animal plasma 6.0 0.0 0.0 6.0 0.0 0.0
Corn oil 3.0 3.0 3.0 3.0 3.0 3.0
Dical phosphate 0.4 1.0 1.7 0.4 1.0 1.7
Limestone 0.3 0.4 0.6 0.3 0.4 0.6
Salt 0.3 0.3 0.3 0.3 0.3 0.3
Swine vit premix 0.3 0.3 0.3 0.3 0.3 0.3
Swine TM premix 0.2 0.2 0.2 0.2 0.2 0.2
L-Lysine HCl 0.0 0.0 0.0 0.0 0.0 0.0
DL-Methionine 0.1 0.0 0.0 0.1 0.0 0.0
Mecadox - 2.5 g/lb 0.0 0.0 0.0 1.0 1.0 1.0
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Table 3. Frequency and serum antibody titers of pigs serologically positive for Mycoplasma hyopneu-
moniae (M. hyo) by the Tween 20 enzyme-linked immunosorbent assay (ELISA).
 Parity Dietary  Vaccinate or No. of Pigs positive Tween 20 serum antibody
  Treatment Saline Control pigs (%)a titers (mean OD + SEM)b
 1 CTL Saline 8 0 0.081
   Vaccinate 8 8 (100) 0.523
 1 AB Saline 8 0 0.077
   Vaccinate 8 7 (87.5) 0.527
 4 CTL Saline 8 0 0.075
   Vaccinate 8 8 (100) 0.452
 4 AB Saline 8 0 0.078
   Vaccinate 8 8 (100) 0.487
aSamples were considered positive if OD ≥ 0.24.
bBack-transformed geometric mean titer + standard error of the mean (SEM).
two pigs (two vaccinates, two saline 
controls) within pens were averaged 
to produce a pen mean M. hyo titer for 
statistical analysis. 
Statistical Analysis
Each pen was considered an 
experimental unit. The model was 
a completely randomized design. 
Growth data were analyzed using 
the MIXED procedure of SAS with 
dietary treatment and parity as the 
main effects of the model. Pen was 
considered as a random effect. Pig BW 
on day 0 was used as a covariate in the 
statistical analyses. 
Results and Discussion
Body weight and growth per-
formance are reported in Table 2. 
There was no parity × dietary treat-
ment interaction for BW during this 
experiment . However, BW of P4 prog-
eny were greater (P < 0.02) than P1 
progeny on day 0, 7, 21, and 42 when 
means were averaged among dietary 
treatments. There were no effects of 
dietary treatment (CTL or AB) on BW 
on day 0, 7, or 21 when means were 
averaged among parities; however, on 
day 42 pigs fed the CTL diet tended to 
have greater (P = 0.054) BW than pigs 
fed the AB diet.
With respect to growth perfor-
mance, no signifi cant parity × dietary 
treatment interaction was observed for 
ADG, ADFI, or G:F during the entire 
length of the study. During Phase I, 
there were no signifi cant main effects 
of parity or dietary treatment on 
ADG or ADFI; however, G:F tended 
(P = 0.08) to increase for P1 progeny 
compared to P4 progeny. During 
Phase II, there were no main effects 
of parity or dietary treatment on ADG 
or G:F; however, ADFI was greater 
(P < 0.005) for P4 progeny compared 
to P1 progeny. During Phase III, P4 
progeny had greater ADFI compared 
to P1 progeny (P < 0.02), and pigs fed 
the CTL diet had greater (P < 0.05) 
G:F and tended (P = 0.08) to have 
greater ADG than pigs fed the AB diet. 
Table 2.  Effect of dam parity and dietary treatment on average body weight (BW), average daily 
gain (ADG), average daily feed intake (ADFI) and feed effi ciency (G:F) of weaned pigs.
 Treatmentsa P-values
Parity 1 1 4 4
Diet CTL AB CTL AB SEMb 1c 2d 3e
No. of pigs 24 24 24 24
BW, lb
day 0 12.681 2.44 14.10 13.85 0.11 0.0001 0.324 0.991
day 7 14.58 13.93 15.46 15.27 0.12 0.001 0.14 0.4
day 21 24.95 25.07 27.47 26.86 0.30 0.007 0.722 0.588
day 42 55.06 52.01 59.79 54.00 0.70 0.014 0.054 0.867
Phase 1 (day 0 to 7)
ADG, lb 0.27 0.21 0.19 0.20 0.01 0.185 0.443 0.307
ADFI, lb 0.28 0.28 0.30 0.31 0.01 0.244 0.908 0.636
G:F, lb/lb 0.97 0.76 0.64 0.66 0.11 0.077 0.393 0.334
Phase 2 (day 8 to 21)
ADG, lb 0.74 0.81 0.86 0.83 0.02 0.145 0.647 0.266
ADFI, lb 0.98 1.05 1.14 1.24 0.02 0.005 0.142 0.804
G:F, lb/lb 0.76 0.78 0.75 0.68 0.04 0.229 0.538 0.282
Phase 3 (day 22 to 42)
ADG, lb 1.43 1.34 1.54 1.40 0.03 0.217 0.082 0.691
ADFI, lb 2.25 2.21 2.47 2.36 0.03 0.02 0.312 0.611
G:F, lb/lb 0.64 0.61 0.62 0.59 0.02 0.303 0.048 0.964
Overall (day 0 to 42)
ADG, lb 1.01 0.97 1.09 1.01 0.02 0.092 0.088 0.554
ADFI, lb 1.50 1.49 1.66 1.64 0.02 0.09 0.641 0.878
G:F, lb/lb 0.68 0.65 0.65 0.61 0.02 0.087 0.07 0.588
aDietary treatments included: parity 1 progeny fed the control diet (P1, CTL), parity 1 progeny fed the 
control diet plus antibiotic (P1, AB), parity 4 progeny fed the control diet (P4, CTL), or parity 4 prog-
eny fed the control diet plus antibiotic (P4, AB).
bStandard Error of the Mean.
cMain effect of parity [(P1, CTL + P1, AB) vs. (P4, CTL + P4, AB)].
dMain effect of dietary treatment [(P1, CTL + P4, CTL) vs. (P1, AB + P4, AB)].
eParity × treatment interaction.
On the day of weaning (day 0), 
four pigs (two barrows, two gilts) 
per pen were randomly chosen and 
vaccinated against Mycoplasma hyo-
pneumoniae (M. hyo; RESPISURE2). 
Two pigs (one barrow, one gilt) were 
given the vaccine and two pigs (one 
barrow, one gilt) were administered a 
saline control. All pigs received booster 
vaccinations (or the appropriate 
saline control) at day 14 and day 28. 
Serum was collected from all pigs at 
the conclusion of the experiment (day 
42) and forwarded to the University 
of Minnesota Veterinary Diagnostic 
Laboratory to be assayed for antibod-
ies to M. hyo by employing the Tween 
20 diagnostic assay. Titer values from (Continued on next page)
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There was no main effect of antibiotic 
on ADFI. Overall (day 0 to 42), P4 
progeny tended (P = 0.09) to have 
greater ADG and ADFI, and decreased 
G:F compared to P1 progeny. In addi-
tion, pigs fed the CTL diet tended 
to have greater ADG (P = 0.09) and 
G:F (P = 0.07) compared to pigs fed 
the AB diet. The trend for increased 
growth performance in P4 progeny is 
consistent with previous, unpublished 
reports; however, the tendency for 
AB fed pigs to have decreased growth 
performance is surprising. The effect 
(or lack thereof) of AB on growth 
performance in the current study may 
be explained by the overall high health 
status of the pigs and that these pigs 
had been reared in an environment 
where an antibiotic response is not 
typically detected.
Mean serum antibody titers for 
M. hyo are presented in Figure 1. No 
pigs were serologically positive for 
M. Hyo antibody titers on day 0 or 
14 of the experiment. As expected, all 
pigs vaccinated against M. hyo (with 
the exception of one pig) were sero-
positive on day 42. 
The frequency and serum anti-
body titers of pigs serologically 
positive for M. hyo on day 42 of the 
experiment are presented in Table 3. 
There were no effects of parity, dietary 
treatment, or their interaction on M. 
hyo titers. These data are presented 
with the caveat that titers to M. hyo is 
only one means by which an immune 
response may be measured. Many 
factors may contribute to overall 
health status and more research may 
be warranted to adequately gauge 
immune response and overall health 
status among progeny derived from 
different parities.
Conclusion
Dam parity may affect growth 
performance of weaned pigs through-
out the nursery period. Additional 
research is needed to determine the 
effects of dam parity on animal health 
in the nursery and on growth per-
formance through the growing and 
fi nisher phases of production.
1Erin E. Carney, Huyen Tran, and Justin W. 
Bundy are graduate students; Roman Moreno 
is a graduate student and research technologist; 
Phillip S. Miller is a professor; and Thomas E. 
Burkey is an assistant professor in the Ani-
mal Science Department at the University of 
Nebraska –Lincoln.
2 The authors wish to thank Pfi zer Animal 
Health for providing Respisure and for subse-
quent analytical analyses.
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Figure 1. Mean serum antibody titers for Mycoplasma hyopneumoniae (M. hyo) by the Tween 20 enzyme-linked immunosorbent assay (ELISA) on day 
0, 14 and 42 of the experiment. Each bar represents the back-transformed geometric mean titer expressed as optical density (OD) + standard 
error of the mean (SEM). Dietary treatments included: parity 1 progeny fed the control diet (P1, CTL), parity 1 progeny fed the control diet 
plus antibiotic (P1, AB), parity 4 progeny fed the control diet (P4, CTL), or parity 4 progeny fed the control diet plus antibiotic (P4, AB).
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